CVAT · Cavitation Technologies, Inc.

OTC MARKETS - Real Time Price • USD

Cavitation Technologies Inc (CVAT)

OTC MARKETS Electrical Equipment
Move probability → Options chain →
$0.03 +0.00 (+2.21%)
● Overnight
DAY'S RANGE $0.03
$0.03 $0.03
52-WEEK RANGE $0.03
$0.02 $0.11

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$12.0M
P/E (TTM1)—
EPS2 (TTM)$-0.00
Div Yield—
Beta31.34
Volume—
Open0.03
Prev Close0.03
Bid / Ask— / —
Next Earnings 2026-11-11

Analyst Recommendations

No analyst recommendation data available.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
CVAT -35.10%
vs S&P 500 -47.88%
1-YEAR RETURN
CVAT -45.92%
vs S&P 500 -60.48%
6-MONTH RETURN
CVAT -22.74%
3-MONTH RETURN
CVAT +11.51%

Valuation Measures & Ratios

Enterprise Value4$12.4M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1089.21
Price / Book7101.51
EV4 / Revenue1124.22
EV4 / EBITDA30.69
Profit Margin-6472.73%
Operating Margin-6490.91%
Return on Equity (ROE8)-252.72%
Return on Assets (ROA9)-994.14%
Avg Volume (3M)465,710
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short4,797
Change from Prior Settlement+22.06%
% of Float—
Days to Cover (Short Ratio)1.00

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Mar '26Dec '25Sep '25Mar '25Dec '24Sep '24Mar '24Dec '23
Revenue $3.0K $0 $3.0K $122.0K $76.0K $0 $519.0K $192.0K
Gross profit $3.0K $0 — $97.0K $63.0K — $512.0K $158.0K
Operating income -$231.0K -$474.0K -$249.0K -$228.0K -$299.0K -$226.0K $333.0K -$14.0K
Net income -$219.0K -$476.0K -$258.0K -$230.0K $579.0K -$227.0K $331.0K -$16.0K
EPS (diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $45.0K $66.0K $55.0K $60.0K $297.0K $576.0K $718.0K $77.0K
Total liabilities $738.0K $533.0K $303.0K $249.0K $228.0K $277.0K $741.0K $784.0K
Stockholders' equity -$693.0K -$467.0K -$248.0K -$189.0K $69.0K $299.0K -$23.0K -$707.0K
Total current assets $34.0K $55.0K $44.0K $49.0K $286.0K $565.0K $701.0K $42.0K
Total current liabilities $588.0K $383.0K $153.0K $99.0K $78.0K $150.0K $613.0K $656.0K
Cash & equivalents $17.0K $45.0K $31.0K $30.0K $249.0K $432.0K $681.0K $2.0K

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$228.0K -$126.0K -$182.0K -$219.0K -$182.0K -$248.0K -$201.0K -$175.0K
Investing cash flow $0 $0 $0 — $0 $0 $880.0K —
Financing cash flow $200.0K $140.0K $183.0K $0 -$1.0K -$1.0K $0 -$2.0K
Capital expenditures — — — — — — — —
Depreciation & amortization — — — — — — — —
Share-based compensation — — — — — — — —

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding CVAT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 13 most recent filings · covers 2008-10-29 to 2023-03-23

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Voloshin NaumChief Executive OfficerOpen market purchase2023-03-23841,000
GORDON ROMANCTODisposition to issuer2016-02-161,000,000
GORODNITSKY IGORPresidentDisposition to issuer2012-12-183,000,000
Zelek ToddCEOGrant / award2012-02-162,000,000
FULLER JAMES WDirectorGrant / award2012-02-0737,500
HARTSHORN R LCFOGrant / award2010-10-08250,000

Recent transactions

DateInsiderTitleTransactionSharesPrice

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 00:38 UTC

FiledFormReport periodOfficial filing
2026-10-138-K2026-10-13 View on SEC.gov →
2026-10-0610-K2026-06-30 View on SEC.gov →
2026-08-198-K2026-08-14 View on SEC.gov →
2026-05-2010-Q2026-03-31 View on SEC.gov →
2026-02-1710-Q2025-12-31 View on SEC.gov →
2025-11-1310-Q2025-09-30 View on SEC.gov →
2025-09-2910-K2025-06-30 View on SEC.gov →
2025-05-1510-Q2025-03-31 View on SEC.gov →
2025-02-1410-Q2024-12-31 View on SEC.gov →
2024-11-1410-Q2024-09-30 View on SEC.gov →
2024-09-3010-K2024-06-30 View on SEC.gov →
2024-09-168-K2024-09-16 View on SEC.gov →

Headlines about CVAT (Cavitation Technologies, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist